세계의 의약품 물류 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Pharmaceutical Logistics Market is presumed to reach the market size of nearly USD 225.53 Billion by 2032 from USD 97.07 Billion in 2023 with a CAGR of 9.82% under the study period 2024-2032.

Pharmaceutical logistics refers to managing pharmaceutical products' storage, transportation, and distribution from manufacturing facilities to end-users, such as pharmacies, hospitals, and clinics. This includes ensuring proper temperature control, handling regulatory requirements, & maintaining product integrity throughout the supply chain. Effective logistics are essential to ensure the timely and safe delivery of medications to patients while minimizing costs and reducing the risk of product damage or loss.

MARKET DYNAMICS

The factors driving the pharmaceutical logistics market include the globalization of pharmaceutical supply chains & the increasing demand for efficient and secure transportation and storage of pharmaceutical products. Pharmaceutical logistics are critical in ensuring pharmaceuticals' timely and safe delivery from manufacturers to healthcare providers and patients. With the expansion of pharmaceutical markets worldwide and the rise of specialty drugs and biologics that require specialized handling and temperature control, there is a growing need for sophisticated logistics solutions customized to the distinct requirements of the pharmaceutical industry. Additionally, stringent regulatory requirements and quality standards governing the transportation and distribution of pharmaceutical products drive the demand for compliant logistics services. Moreover, technological advancements, such as cold chain monitoring systems and track-and-trace technology, enhance supply chain visibility and transparency, improving efficiency and reducing the risk of product loss or damage. Furthermore, the increasing adoption of just-in-time inventory management practices and the rise of e-commerce in pharmaceutical distribution further stimulate market growth by increasing demand for last-mile delivery and fulfillment services. However, logistical challenges and regulatory complexities may hinder the pharmaceutical logistics market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Pharmaceutical Logistics. The growth and trends of Pharmaceutical Logistics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Pharmaceutical Logistics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Cold Chain Logistics
• Non-Cold Chain Logistics

By Component

• Storage (Warehouse, Refrigerated Container)
• Transportation (Sea freight Logistics, Airfreight Logistics, Overland Logistics)
• Monitoring components (Hardware (Sensors, RFID Devices, Telematics, Networking Devices),Software)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pharmaceutical Logistics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pharmaceutical Logistics market include Agility, Air Canada, CEVA Logistics, DB Schenker, Deutsche Post AG, FedEx, LifeConEx, Marken, United Parcel Service Of America Inc., VersaCold Logistics Services. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. PHARMACEUTICAL LOGISTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Component
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PHARMACEUTICAL LOGISTICS MARKET ANALYSIS BY TYPE

• 5.1. Overview By Type
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Type
• 5.4. Cold Chain Logistics Historic and Forecast Sales By Regions
• 5.5. Non-Cold Chain Logistics Historic and Forecast Sales By Regions

6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET ANALYSIS BY COMPONENT

• 6.1. Overview By Component
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Component
• 6.4. Storage (Warehouse, Refrigerated Container) Historic and Forecast Sales By Regions
• 6.5. Transportation (Sea freight Logistics, Airfreight Logistics, Overland Logistics) Historic and Forecast Sales By Regions
• 6.6. Monitoring components (Hardware (Sensors, RFID Devices, Telematics, Networking Devices),Software) Historic and Forecast Sales By Regions

7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE PHARMACEUTICAL LOGISTICS COMPANIES

• 8.1. Pharmaceutical Logistics Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF PHARMACEUTICAL LOGISTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Agility
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. Air Canada
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. CEVA Logistics
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. DB Schenker
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. Deutsche Post AG
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. FedEx
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. LifeConEx
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments
• 9.10. Marken
  • 9.10.1 Company Overview
  • 9.10.2 Company Revenue
  • 9.10.3 Products
  • 9.10.4 Recent Developments
• 9.11. United Parcel Service Of America Inc.
  • 9.11.1 Company Overview
  • 9.11.2 Company Revenue
  • 9.11.3 Products
  • 9.11.4 Recent Developments
• 9.12. VersaCold Logistics Services
  • 9.12.1 Company Overview
  • 9.12.2 Company Revenue
  • 9.12.3 Products
  • 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies